JUPITER NEUROSCIENCES, INC. (JUNS) - Dilution Analysis

8-K filing: The Company has issued and sold approximately 12.5 million shares of common stock to Yorkville under a Standby Equity Purchase Agreement for net proceeds of approximately $4.1 million. ($4.1M proceeds)

S-1 filing: This filing registers up to 16,000,000 shares of common stock to be issued to Yorkville from time to time pursuant to a Standby Equity Purchase Agreement (SEPA).

8-K filing: Jupiter Neurosciences, Inc. entered into a securities purchase agreement to issue and sell 7,142,858 shares of common stock at $0.28 per share for gross proceeds of approximately $2.0 million. ($2.0M proceeds)

10-Q filing | 35.3M shares outstanding

S-1 filing: This prospectus relates to the resale of up to 10,000,000 shares of common stock by YA II PN, LTD.

10-Q filing | 34.0M shares outstanding

8-K filing: Jupiter Neurosciences, Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD, allowing the Company to sell up to $20.0 million of its common stock to Yorkville, and also issued convertible promissory notes to Yorkville for a Pre-Paid Advance. ($0.2M proceeds)

10-Q filing | 33.1M shares outstanding

10-K filing | 33.1M shares outstanding

10-Q filing | 31.1M shares outstanding

8-K filing: Jupiter Neurosciences, Inc. completed a firm commitment underwritten initial public offering of 2,750,000 shares of common stock at $4.00 per share on December 4, 2024, resulting in gross proceeds of $11,000,000 and net proceeds of approximately $9.5 million. ($11.0M proceeds)

S-1/A filing: This S-1/A filing discusses the expenses related to the offer and sale of common stock by the company and selling stockholders, as well as indemnification of directors and officers.

S-1/A filing: This is an S-1/A filing for an initial public offering of common stock and resale of common stock by selling stockholders.

S-1/A filing: This is an S-1/A filing for an initial public offering of common stock, where the company is offering 2,750,000 shares and certain shareholders are registering the resale of 3,600,000 shares.

S-1/A filing: This is an S-1/A filing for an initial public offering of common stock and resale of common stock by certain shareholders.

S-1/A filing: This is an S-1/A filing for an initial public offering of common stock and a resale of common stock by selling stockholders.

S-1/A filing: Initial public offering of 2,608,695 shares of common stock at an expected price of $5.75 per share.

S-1/A filing: This is a firm commitment initial public offering of 2,608,695 shares of common stock at an expected price of $5.75 per share.

S-1/A filing: This is a firm commitment initial public offering of 2,608,695 shares of common stock with an expected initial public offering price of $5.75 per share.

S-1/A filing: This is a firm commitment initial public offering of 2,608,695 shares of common stock by Jupiter Neurosciences, Inc. at an assumed initial public offering price of $5.75 per share.

S-1/A filing: This is a firm commitment initial public offering of 2,500,000 shares of common stock. The initial public offering price is expected to be between $5.00 and $7.00 per share.

S-1/A filing: Initial public offering of 2,500,000 shares of common stock with an expected price between $5.00 and $7.00 per share.

S-1/A filing: Initial public offering of 2,200,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an expected price between $6.00 and $8.00 per unit.

S-1/A filing: Initial public offering of 2,200,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an expected IPO price between $6.00 and $8.00 per unit.

S-1/A filing: This is a firm commitment initial public offering of Jupiter Neurosciences, Inc., offering 2,200,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock.

S-1/A filing: This is a firm commitment initial public offering of Jupiter Neurosciences, Inc., offering 2,200,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an expected price between $6.00 and $8.00 per unit.

S-1/A filing: This is a firm commitment initial public offering of 2,200,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an expected price between $6.00 and $8.00 per unit.

S-1/A filing: Jupiter Neurosciences, Inc. is offering 2,200,000 units at an expected price between $6.00 and $8.00 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $7.00.

S-1/A filing: The filing is an S-1/A form, indicating an initial public offering of 2,200,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an expected price between $6.00 and $8.00 per unit. It also includes an option for the underwriters to purchase an additional 330,000 shares of common stock and/or warrants.

S-1/A filing: This is a firm commitment initial public offering of 3,333,333 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, with an expected price between $5.00 and $7.00 per unit.

S-1/A filing: This is a firm commitment initial public offering of Jupiter Neurosciences, Inc., offering 3,333,333 units, each consisting of one share of common stock and one warrant to purchase one share of common stock.

S-1/A filing: This is a firm commitment initial public offering of Jupiter Neurosciences, Inc., offering 3,333,333 units at an expected price between $5.00 and $7.00 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.

S-1 filing: Jupiter Neurosciences, Inc. is conducting a firm commitment initial public offering of units, each consisting of one share of common stock and one warrant to purchase one share of common stock. The offering also includes the shares of common stock issuable from time to time upon exercise of the warrants. Dawson James Securities, Inc. is the underwriter.